Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particles

Mostrar otras versiones (1)

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant contains extensive sequence changes relative to the earlier-arising B.1, B.1.1, and Delta SARS-CoV-2 variants that have unknown effects on viral infectivity and response to existing vaccines. Using SARS-CoV-2 virus-like...

Descripción completa

Detalles Bibliográficos
Autores principales: Syed, Abdullah M., Ciling, Alison, Taha, Taha Y., Chen, Irene P., Khalid, Mir M., Sreekumar, Bharath, Chen, Pei-Yi, Kumar, G. Renuka, Suryawanshi, Rahul, Silva, Ines, Milbes, Bilal, Kojima, Noah, Hess, Victoria, Shacreaw, Maria, Lopez, Lauren, Brobeck, Matthew, Turner, Fred, Spraggon, Lee, Tabata, Takako, Ott, Melanie, Doudna, Jennifer A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2022
Materias:
Biological Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351483/
https://www.ncbi.nlm.nih.gov/pubmed/35858386
http://dx.doi.org/10.1073/pnas.2200592119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351483/
https://www.ncbi.nlm.nih.gov/pubmed/35858386
http://dx.doi.org/10.1073/pnas.2200592119

Ejemplares similares